Ingria Pratama Capitalindo Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Ingria Pratama Capitalindo Tbk. trades at Rp110 (market cap 811.33B, 10.51M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp246 (market cap 167.37B, 71K 24h volume). The key difference: Ingria Pratama Capitalindo Tbk. is far larger — about 4.8× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Ingria Pratama Capitalindo Tbk. is more actively traded (10.51M versus 71K). Which is the better fit depends on your goals.
| GRIA | OBAT | |
|---|---|---|
Market Cap | 811.33B | 167.37B |
Volume | 10.51M | 71K |
Lot | 105.06K | 710 |
Turnover | 1.19B | 17.51M |
Average Price | 113.06 | 246.63 |
Value | 1.19B | 17.51M |
Indicative Equilibrium Price | 110 | 246 |
Indicative Equilibrium Volume | 745 | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Ingria Pratama Capitalindo Tbk (the “Company”) was established based on Notarial Deed No. 04 dated 8 May 2013 of Euis Widari, S.H. The Company commenced its operationalactivity with purchases of land in 2017.
Read more on GRIA →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →